1. Qin, Yingying, Sun, Mei, You, Li, Xu, Jianfeng, Chen, Zi-Jiang. 2012. ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failure. In Orphanet journal of rare diseases, 7, 5. doi:10.1186/1750-1172-7-5. https://pubmed.ncbi.nlm.nih.gov/22248077/
2. Zhang, Wei, Zhao, Enyang, Li, Zhuolun, Li, Xuedong, You, Bosen. 2024. Hexokinase HK3-mediated O-GlcNAcylation of EP300: a key regulator of PD-L1 expression and immune evasion in ccRCC. In Cell death & disease, 15, 613. doi:10.1038/s41419-024-06921-1. https://pubmed.ncbi.nlm.nih.gov/39179546/
3. Li, Shupeng, Li, Ziwei, Wang, Xinyu, Meng, Xiangqi, Cai, Jinquan. 2023. HK3 stimulates immune cell infiltration to promote glioma deterioration. In Cancer cell international, 23, 227. doi:10.1186/s12935-023-03039-w. https://pubmed.ncbi.nlm.nih.gov/37779195/
4. Zhu, Mingyu, Tang, Xiaokai, Xu, Jingjing, Gong, Yuanqi. 2024. Identification of HK3 as a promising immunomodulatory and prognostic target in sepsis-induced acute lung injury. In Biochemical and biophysical research communications, 706, 149759. doi:10.1016/j.bbrc.2024.149759. https://pubmed.ncbi.nlm.nih.gov/38484574/
5. Tuo, Zhan, Zheng, Xin, Zong, Yan, Lv, Yi, Liu, Jun. . HK3 is correlated with immune infiltrates and predicts response to immunotherapy in non-small cell lung cancer. In Clinical and translational medicine, 10, 319-330. doi:10.1002/ctm2.6. https://pubmed.ncbi.nlm.nih.gov/32508023/
智鼠故事 
